Table 2 Potential enteropathogens identified in patients (n = 243) and population controls (n = 124)
| Â | Study group | Control group | odds ratio b | p-value c |
|---|---|---|---|---|
Enteropathogens | No. of findings(%) | No. of findings (%) | adjusted for age and sex (95 % CI) | Â |
Viruses a | 178 (73.3) | 57 (46.0) | 3.27 (2.1 to 5.2) | < 0.0001 |
Rotavirus | 133 (54.7) | 15 (12.1) | 7.73 (4.2 to 14.2) | < 0.0001 |
Adenovirus | 67 (27.6) | 39 (31.5) | 1.12 (0.7 to 1.9) | 0.7 |
Norovirus | 23 (9.5) | 11 (8.9) | 0.84 (0.4 to 1.8) | 0.7 |
Astrovirus | 11 (4.5) | 2 (1.6) | 2.53 (0.6 to 11.7) | 0.2 |
Parasites a | 12 (4.9) | 16 (12.9) | 0.56 (0.2 to 1.3) | 0.2 |
Giardia lamblia | 9 (3.7) | 12 (9.7) | 0.56 (0.2 to 1.5) | 0.2 |
Cryptosporidium sp. | 1 (0.4) | 1 (0.8) | - | - |
Hymenolepis nana | 2 (0.8) | 1 (0.8) | - | - |
Strongyloides stercoralis | 1 (0.4) | 1 (0.8) | - | - |
Ancylostoma duodenale | 1 (0.4) | 1 (0.8) | - | - |
Bacteria a | 12 (4.8) | 2 (1.6) | 4.8 (0.9 to 27.0) | 0.07 |
Salmonella enterica sp. | 6 (2.4) | 0 (0.0) | - | - |
Campylobacter sp. | 2 (0.8) | 1 (0.8) | - | - |
Shigella sp. | 4 (1.6) | 1 (0.8) | - | - |